News Focus
News Focus
icon url

tomtomboombang

01/13/05 2:57 AM

#17613 RE: tomtomboombang #17612

ACAD - Acadia Pharmaceuticals-ACAD shares significantly undervalued-
opinion @ PIPR steady - With three Phase II CNS programs, we expect 2005 to be a breakout year for ACAD.